On September 26, 2017 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that President and CEO Stephen Yoder will present a corporate overview and meet with investors at the LEERINK Partners Roundtable Series on Rare Disease and Immuno-Oncology (Press release, Pieris Pharmaceuticals, SEP 26, 2017, View Source [SID1234520652]). The conference will take place September 27-28 at the Lotte New York Palace, New York, NY.

Mr. Yoder is scheduled to present on Thursday, September 28 at 9:30 AM ET. The presentation will be webcast live and can be accessed on the day of his presentation and for 90 days thereafter via this link.